Shifts in patient preference of third‐line overactive bladder therapy after introduction of the implantable tibial nerve stimulator

• Published in: Neurourology and urodynamics Vol. 43; no. 4; pp. 959 - 966
• Main Authors: Kapur, Anjali, Aalami Harandi, Arshia, Hartman‐Kenzler, Jacob, Kim, Jason
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.04.2024
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Botulinum Toxins, Type A - therapeutic use; Child; Comorbidity; Electric Stimulation Therapy; Female; Humans; implantable tibial nerve stimulation; Male; Middle Aged; Neuromodulation; overactive bladder; Patient Preference; Patients; Phenotypes; Preferences; Surveys; third‐line therapies; Tibial Nerve; Transcutaneous Electric Nerve Stimulation; Treatment Outcome; Urinary Bladder, Overactive - therapy; Urinary incontinence; Young Adult; overactive bladder; implantable tibial nerve stimulation; third‐line therapies

Introduction Third‐line therapies for overactive bladder (OAB) that are currently recommended include intravesical Onabotulinumtoxin‐A injections (BTX‐A), percutaneous tibial nerve stimulation (PTNS), and sacral neuromodulation (SNM). The implantable tibial nerve stimulator (ITNS) is a novel therapy...